166
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Long-Term Survival With Allogeneic Stem Cell Transplant and Donor Lymphocyte Infusion Following Salvage Therapy with Anti-CD52 Monoclonal Antibody (Campath) in a Patient with α/β Hepatosplenic T-Cell Non-Hodgkin's Lymphoma

, , , , , , , , & show all
Pages 1673-1675 | Received 25 Apr 2003, Published online: 26 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Masahiko Sumi, Wataru Takeda, Hiroko Kaiume, Takehiko Kirihara, Taro Kurihara, Keijiro Sato, Toshimitsu Ueki, Yuki Hiroshima, Mayumi Ueno, Naoaki Ichikawa & Hikaru Kobayashi. (2015) Successful treatment with reduced-intensity cord blood transplant in a patient with relapsed refractory hepatosplenic T-cell lymphoma. Leukemia & Lymphoma 56:4, pages 1140-1142.
Read now
Sandra Bašić Kinda, Nadira Duraković, Snježana Dotlić, Ranka Serventi Seiwerth, Sanja Davidović Mrsić, Klara Dubravčić & Igor Aurer. (2013) Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant. Leukemia & Lymphoma 54:6, pages 1334-1335.
Read now
Simon He, Andrew Roberts, David Ritchie & Andrew Grigg. (2007) Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma. Leukemia & Lymphoma 48:7, pages 1448-1450.
Read now

Articles from other publishers (25)

Robert N. Stuver, Mwanasha Merrill & Salvia Jain. 2021. The Peripheral T‐Cell Lymphomas. The Peripheral T‐Cell Lymphomas 225 234 .
Barbara ProPamela Allen & Amir Behdad. (2020) Hepatosplenic T-cell lymphoma: a rare but challenging entity. Blood 136:18, pages 2018-2026.
Crossref
Daniella Klebaner, Divya Koura, Dimitrios Tzachanis, Edward D. Ball, Steven Horwitz & Aaron M. Goodman. (2020) Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 20:7, pages 431-437.e2.
Crossref
Preethi Ramachandran, Alok Aggarwal & Jen Chin Wang. 2019. Peripheral T-cell Lymphomas. Peripheral T-cell Lymphomas.
Hui Pan, Jing Huang, Jun-Nan Li, Li Yang, Jian-Yu Wang, Xin Wang, Lin Liu, Ze-Song Yang & Li Wang. (2018) Successful second allogeneic stem-cell transplantation from the same sibling donor for a patient with recurrent hepatosplenic gamma-delta (γ/δ) T-cell lymphoma. Medicine 97:44, pages e12941.
Crossref
Yang Shi & Endi Wang. (2015) Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review With an Emphasis on Diagnostic Differentiation From Other T-Cell/Natural Killer–Cell Neoplasms. Archives of Pathology & Laboratory Medicine 139:9, pages 1173-1180.
Crossref
A Rashidi & A F Cashen. (2015) Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma. Blood Cancer Journal 5:6, pages e318-e318.
Crossref
Marco Foppoli & Andrés J. M. Ferreri. (2014) Gamma‐delta t‐cell lymphomas. European Journal of Haematology 94:3, pages 206-218.
Crossref
Jia Wei, Jinhuan Xu, Yang Cao, Jianfeng Zhou & Yicheng Zhang. (2015) Allogeneic Stem-Cell Transplantation for Peripheral T-Cell Lymphoma: A Systemic Review and Meta-Analysis. Acta Haematologica 133:2, pages 136-144.
Crossref
Nishitha M. Reddy & Andrew M. Evens. (2014) Chemotherapeutic Advancements in Peripheral T-Cell Lymphoma. Seminars in Hematology 51:1, pages 17-24.
Crossref
Max Schlaak, Juliane Pickenhain, Sebastian Theurich, Nicole Skoetz, Michael von Bergwelt-Baildon & Peter Kurschat. (2013) Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma. Cochrane Database of Systematic Reviews.
Crossref
Koppany Visnyei, Michael L. Grossbard & Ilan Shapira. (2013) Hepatosplenic γδ T-cell Lymphoma: An Overview. Clinical Lymphoma Myeloma and Leukemia 13:4, pages 360-369.
Crossref
Armin Rashidi, Michael E. Lee & Stephen I. Fisher. (2012) Hepatosplenic αβ T-cell lymphoma associated with azathioprine therapy. International Journal of Hematology 95:5, pages 592-594.
Crossref
Marjana Glaser, Aleš Goropevšek, Rajko Kavalar & Andrej Glaser. (2012) Hepatosplenic Gamma-Delta T-Cell Lymphoma in a Female Patient after Delivery. Hematology Reports 4:1, pages e4.
Crossref
Max Schlaak, Juliane Pickenhain, Sebastian Theurich, Nicole Skoetz, Michael von Bergwelt-Baildon & Peter Kurschat. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Claire E. Dearden, Rod Johnson, Ruth Pettengell, Stephen Devereux, Kate Cwynarski, Sean Whittaker & Andrew McMillan. (2011) Guidelines for the management of mature T‐cell and NK‐cell neoplasms (excluding cutaneous T‐cell lymphoma). British Journal of Haematology 153:4, pages 451-485.
Crossref
Anne Thai & Thomas Prindiville. (2010) Hepatosplenic T-cell lymphoma and inflammatory bowel disease. Journal of Crohn's and Colitis 4:5, pages 511-522.
Crossref
Yuya Nagai, Kazuhiro Ikegame, Minako Mori, Daichi Inoue, Takaharu Kimura, Sonoko Shimoji, Katsuhiro Togami, Sumie Tabata, Masayuki Kurata, Yukihiro Imai, Akiko Matsushita, Kenichi Nagai, Hiroyasu Ogawa & Takayuki Takahashi. (2010) Hepatosplenic αβ T cell lymphoma. International Journal of Clinical Oncology 15:2, pages 215-219.
Crossref
Amit W. Panwalkar & James O. Armitage. (2007) T-cell/NK-cell lymphomas: A review. Cancer Letters 253:1, pages 1-13.
Crossref
H.J. Meulenbeld, W. Spiering, P. Nooijen, W. Peters & G.J. Creemers. (2007) Hepatosplenic γδ T-cell lymphoma: A case report. European Journal of Internal Medicine 18:3, pages 241-243.
Crossref
S. Mittal, B. J. Milner, P. W. Johnston & D. J. Culligan. (2006) A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to Fludarabine and Alemtuzumab. European Journal of Haematology 76:6, pages 531-534.
Crossref
Mujahid A. RizviAndrew M. EvensMartin S. TallmanBeverly P. NelsonSteven T. Rosen. (2006) T-cell non-Hodgkin lymphoma. Blood 107:4, pages 1255-1264.
Crossref
Vít Procházka, Tomáš Papajík, Marie Jarošová, Zuzana Pikalová, Karel Indrák, Martin Tichý, Ladislava Kučerová, František Fakan, Milan Bílý & David Starostka. (2005) T-cell gamma/delta hepatosplenic lymphoma - prolonged remission induced by aggressive first line treatment. Biomedical Papers 149:2, pages 275-276.
Crossref
G G Wulf, J Hasenkamp, W Jung, B Chapuy, L Truemper & B Glass. (2005) Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma. Bone Marrow Transplantation 36:3, pages 271-273.
Crossref
M R Mansour, A Dogan, E C Morris, A Khwaja, D C Linch, S Mackinnon & K S Peggs. (2005) Allogeneic transplantation for hepatosplenic αβ T-cell lymphoma. Bone Marrow Transplantation 35:9, pages 931-934.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.